Search For "anti viral"
GNP can be used as 'composite therapeutic agent' in clinical trials: Dr Ha
Updated : 5 years, 11 months ago IST
New Delhi [India], June 30 (ANI): Union Health Minister Dr Harsh Vardhan on Tuesday said that the Gold Nanoparticles synthesized by the National Centre for Polar and Ocean Research and Goa University can be used as a "composite therapeutic agent" in clinical trials for anti-cancer, anti-vira
Read More
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 5 years, 11 months ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More
Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell
Updated : 5 years, 11 months ago IST
New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" on COVID-19 patients with moderate
Read More
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate C
Updated : 5 years, 11 months ago IST
New Delhi [India], June 20 (ANI): Domestic pharmaceuticals Glenmark on Saturday informed that their antiviral drug -- Favipiravir -- has shown clinical improvement of up to 88 per cent in mild to moderate COVID-19 cases, including those with co-morbidities.
Read More
Anti-viral drug favipiravir gets DGCI nod for 'restricted emergency use' i
Updated : 5 years, 11 months ago IST
New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral drug favipiravir for "restricted emergency use" in mild to moderate cases of COVID-19, a senior government official confirmed to ANI.
Read More
Tevero becomes the first brand to launch masks in India finished with text
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 17 (ANI/PRNewswire): The Coronavirus Pandemic is a problem that is unfortunately here to stay. A virus, spread so far and wide is going to be challenging to eradicate.
Read More
COVID-19: Coimbatore based textile company develops anti-viral fabric
Updated : 5 years, 11 months ago IST
Coimbatore (Tamil Nadu) [India], June 16 (ANI): A Coimbatore based textile company claims to have developed an antiviral fabric to contain the spread of coronavirus.
Read More
India to soon begin domestic production of Remdesivir drug to fight COVID-
Updated : 5 years, 11 months ago IST
New Delhi [India], June 13 (ANI): India is soon going to have its domestic production of anti-viral Remdesivir drug, which would have safety, efficacy and stability for "restricted emergency use" on COVID-19 patients.
Read More
Tevero becomes the first brand to launch masks in India finished with text
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 12 (ANI/PRNewswire): The coronavirus pandemic is a problem that is unfortunately here to stay. A virus, spread so far and wide is going to be challenging to eradicate.
Read More
Arvind announces launch of revolutionary anti-viral fabrics under its Inte
Updated : 5 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 11 (ANI/BusinessWire India): While fabrics have been usually associated with fashion, as the world faces the COVID-19 crisis, there is an urgent need for antiviral fabrics in our daily lives. Arvind Limited, India's leading textile-to-retail conglomerate to
Read More
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesiv
Updated : 5 years, 12 months ago IST
New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and sell anti-viral drug 'Remdesivir' in India to combat COVID-19
Read More
COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on
Updated : 6 years ago IST
New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergency use" o
Read More